0001610717-24-000130.txt : 20240305
0001610717-24-000130.hdr.sgml : 20240305
20240305165311
ACCESSION NUMBER: 0001610717-24-000130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anders Jack
CENTRAL INDEX KEY: 0001800668
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 24721720
MAIL ADDRESS:
STREET 1: C/O REVOLUTION MEDICINES, INC.
STREET 2: 700 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-03-01
0001628171
Revolution Medicines, Inc.
RVMD
0001800668
Anders Jack
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
Chief Financial Officer
false
Common Stock
2024-03-01
4
A
0
26400
0
A
103220
D
Stock Option (Right to Buy)
29.8
2024-03-01
4
A
0
92400
0
A
2034-02-28
Common Stock
92400
92400
D
Includes 63,726 restricted stock units.
Includes 404 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023.
One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
/s/ Jack Anders
2024-03-05